Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration.

@article{Borowitz2013MaximalDD,
  title={Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: a reconsideration.},
  author={Drucy S. Borowitz and Daniel Gelfond and Karen M Maguiness and James E. Heubi and Bonnie Ramsey},
  journal={Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
  year={2013},
  volume={12 6},
  pages={784-5}
}
The current recommendations for dosing of pancreatic enzyme replacement therapy (PERT) in infants with cystic fibrosis (CF) were made using a limited evidence base. The per meal recommended dose was extrapolated from dosing guidelines for older patients into a maximal daily dose for infants. We discuss why this maximal daily dose recommendation may be insufficient for young infants with CF, although the optimal dose of PERT for infants with CF remains unknown. 

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Pancreatic Enzyme Replacement Therapy (PERT). Dosage recommendations for cystic fibrosis infants

  • C. Leonard
  • NottinghamNeonatal Service— Clinical Guideline F5…
  • 1999
2 Excerpts

Pancreatic enzymes— evaluation of current practice in a large CF clinic

  • D Kalnins, PR Durie, L. Ellis
  • Pediatr Pulmonol
  • 1995
1 Excerpt

Similar Papers

Loading similar papers…